Cite

Figure 1

Correlation between serum microRNA-34a and nonalcoholic fatty liver disease activity score
Correlation between serum microRNA-34a and nonalcoholic fatty liver disease activity score

Figure 2

Level of serum microRNA-34a in control, simple steatosis, and nonalcoholic steatohepatitis (NASH)
Level of serum microRNA-34a in control, simple steatosis, and nonalcoholic steatohepatitis (NASH)

Figure 3

Level of serum microRNA-34a in patients with control, nonalcoholic fatty liver disease activity score (NAS) <4, and NAS≥4
Level of serum microRNA-34a in patients with control, nonalcoholic fatty liver disease activity score (NAS) <4, and NAS≥4

Figure 4

Receiver operating characteristic analysis of serum miR-34a from patients with nonalcoholic fatty liver disease (NAFLD) and NAFLD activity score (NAS) ≥4 versus with NAS <4
Receiver operating characteristic analysis of serum miR-34a from patients with nonalcoholic fatty liver disease (NAFLD) and NAFLD activity score (NAS) ≥4 versus with NAS <4

Baseline demographic and biochemical findings from patients with NAFLD

Characteristics, mean (SD) and number (%)NAFLD patients (n = 50)
Demographics
 Age (year)46.0 (13.7)
 Female patients (%)26 (52)
 Weight (kg)93.0 (43.6)
 Height (m)161.8 (9.6)
 Body Mass Index (BMI) (kg/m2)35.8 (15.8)
Obesity classification (%)
 Normal (BMI <23.0 kg/m2)3 (6)
 Overweight (BMI 23.0-24.9 kg/m2)8 (16)
 Obesity grade 1 (BMI 25.0-29.9 kg/m2)14 (28)
 Obesity grade 2 (BMI 30.0-39.9 kg/m2)9 (18)
 Morbid obesity (BMI >40 kg/m2)16 (32)
Comorbidities (%)
 Metabolic syndrome38 (76)
 Hypertension30 (60)
 Hypercholesterolemia30 (60)
 Diabetes mellitus and impaired fasting glucose27 (54)
 Hypertriglyceridemia15 (30)
Biochemical profile
 Albumin (g/dL)4.3 (0.4)
 Total bilirubin (mg/dL)0.91 (0.39)
 Aspartate aminotransferase (AST) (U/L)50 (32)
 Alanine aminotransferase (ALT) (U/L)71 (45)
 Alkaline phosphatase (ALP) (U/L)75 (22)
 Fasting plasma glucose (mg/dL)114 (36)
 Hemoglobin Alc (%)6.3 (1.2)
 Triglyceride (mg/dL)143 (54)
 Total cholesterol (mg/dL)197 (38)
 High-density lipoprotein (HDL) (mg/dL)43 (10)
 Low-density lipoprotein (LDL) (mg/dL)124 (35)

Liver histological parameters of NAFLD patients

CharacteristicsNAFLD patients (n = 50)
NASH (%)33 (66)
Simple steatosis (%)17 (34)
NAFLD Activity Score (NAS) (%)
  17 (14)
  25 (10)
  311 (22)
  415 (30)
  59 (18)
  63 (6)
Fibrosis score (%)
  FO19 (38)
  Fl20 (40)
  F25 (10)
  F36 (12)
Degree of steatosis (%)
  1 (5-33%)24 (48)
  2 (34-66%)18 (36)
  3 (>66%)8 (16)
Degree of lobular inflammation
  0 (none)14 (28)
  1 (<2 foci/20 fields)27 (54)
  2 (2-4 foci/20 fields)9 (18)
  3 (>4 foci/20 fields)0
Degree of hepatocyte ballooning (%)
  0 (none)16 (32)
  1 (few)24 (48)
  2 (many)10 (20)
eISSN:
1875-855X
Language:
English
Publication timeframe:
6 times per year
Journal Subjects:
Medicine, Assistive Professions, Nursing, Basic Medical Science, other, Clinical Medicine